mesowatch
HomeCalifornia Jury Grants $107M to Janitor's Family
divider

California Jury Grants $107M to Janitor’s Family for Asbestos Death

A diverse group of people sitting in a courtroom

A California jury has awarded approximately $107 million in damages to the family of Joel Hernandezcueva, a 45-year-old janitor who died from mesothelioma, a cancer linked to asbestos exposure. The verdicts returned on July 7 and July 11, concluded a two-phase trial at the Los Angeles County Superior Court.

Joel Hernandezcueva, who lived in Long Beach, worked at a mixed-use development in Irvine, California. His role as a janitor exposed him to asbestos fibers during cleanup operations amid renovations, claimed his family.

Hernandezcueva, who was a father to four children, succumbed to pleural mesothelioma in 2014.

Verdict Details and Defendant Responsibilities

The jury’s decision involved a $32 million compensatory damage award in the first phase of the trial, with an additional $75 million in punitive damages assessed in the second phase. The court’s judgment may also incorporate significant interest amounts, as suggested by the family’s legal team at Dean Omar Branham Shirley LLP.

According to the verdict forms, Union Carbide Corp. was found to be the most culpable, responsible for 46.4% of the negligence that led to Hernandezcueva’s illness. Elementis Chemicals and E.F. Brady Co. Inc. were also found negligent, contributing 5% and 10% to the harm, respectively.

Union Carbide was uniquely found to have acted with malice, according to the jury. Benjamin Adams, representing the Hernandezcueva family, remarked on the company’s awareness of the risks associated with their asbestos products. He criticized Union Carbide for misleading its customers about the safety of its asbestos, even though internal documents reportedly showed a starkly different reality.

Jessica Dean, another attorney for the family, highlighted that Union Carbide had calculated the cost of future cancer claims against the profits from continuing its asbestos operations unabatedly. Over 863 million pounds of asbestos were sold by the company, which it considered justifiable despite the potential legal consequences.

Union Carbide has strongly disagreed with the jury’s findings, particularly criticizing the punitive damages as excessive and not in line with California law. The company described the verdict as “runaway” and plans to seek its reversal on appeal, arguing that the decision does not align with the intended purpose of punitive damages, which is to influence corporate behavior.

The lawsuit, initiated in 2011 before Hernandezcueva’s death, had seen several rounds in court, including a previous trial in 2013 and subsequent appeals that overturned earlier rulings favoring the defendants. During the latest trial, Union Carbide’s motions for a mistrial—based on claims of prejudicial statements by the plaintiff’s counsel—were denied.

Matthew Davis

Reading Time: 1 mins

Published On: July 12, 2023

Matthew Davis - author

Matthew Davis is a freelance journalist who has covered civil litigation for a variety of publications. He joined Mesowatch in 2016 and covers asbestos litigation developments in the U.S., as well as newsworthy asbestos cases.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer